Innovatives medicines

Genetrix Group is developing several innovatives medicines aiming at a large unmet clinical needs, such as the consequences of myocardial infarction, Parkinson’s disease and Rheumatoid Arthritis. To treat these complex diseases, Genetrix has been researching on the potential of several adult stem cells lineages for the last ten years.